RenovoRx, Inc. (RNXT) Financials
RNXT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 11.5 million | 2.5 million |
| March 31, 2026 | 14.0 million | 2.7 million |
| Dec. 31, 2025 | 8.1 million | 2.7 million |
| Sept. 30, 2025 | 11.2 million | 3.1 million |
RNXT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -2.9 million | 570000 |
| March 31, 2026 | -3.7 million | 317000 |
| Dec. 31, 2025 | -3.0 million | 285000 |
| Sept. 30, 2025 | -2.3 million | 349000 |
RNXT Net Income
No data available :(
RNXT Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 9.5 million | - | 259000 |
| March 31, 2026 | 12.4 million | 78000 | 108000 |
| Dec. 31, 2025 | 7.0 million | 107000 | 105000 |
| Sept. 30, 2025 | 10.0 million | - | 236000 |
RNXT Shares Outstanding
RNXT Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 71000 | 1.2 million | 2.9 million | - |
| March 31, 2026 | 66000 | 1.2 million | 2.7 million | - |
| Dec. 31, 2025 | - | 1.5 million | 2.2 million | - |
| Sept. 30, 2025 | - | 1.7 million | 1.7 million | - |
RNXT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 909000 | 143000 |
| March 31, 2026 | 563000 | 84000 |
| Dec. 31, 2025 | 238000 | 28000 |
| Sept. 30, 2025 | 266000 | 53000 |
RNXT Revenue by Segment
Graph available only for paid members. Upgrade to see it.
RNXT
Price: $1.20
52 week price:
Earnings Per Share: -0.27 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 20500
Market Capitalization: 66.2 million